All In Biotech

Free tool

FAERS Monitor: Ztlido

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207962 or its brand name (Ztlido, Lidocaine). Reports on generic versions are filed under their own applications.

Reports

49,881

Serious

36,261

73% of reports

Hospitalization

17,871

Death reported

5,056

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,715
  • pain3,226
  • fatigue3,117
  • nausea3,103
  • headache2,866
  • off label use2,726
  • dyspnoea2,224
  • pneumonia2,056
  • diarrhoea2,017
  • sinusitis1,952
  • vomiting1,889
  • product dose omission issue1,772
  • fall1,745
  • dizziness1,743
  • death1,713

Reports by year received

View as table
YearReports
2004281
2005257
2006318
2007314
2008376
2009451
2010531
20111,089
20121,215
2013757
20141,133
20151,871
20163,208
20172,539
20183,298
20194,174
20205,431
20213,793
20223,546
20233,900
20244,006
20254,135
20263,254

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,004,278 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sinusitisSignal1,9528.27.812,096
pneumoniaSignal2,0562.72.62,198
product dose omission issueSignal1,7722.62.41,682
painSignal3,2262.22.12,217
fallSignal1,7452.22.11,177
headache2,8661.91.91,321
vomiting1,8891.71.6550
fatigue3,1171.71.6909
dyspnoea2,2241.71.6596
nausea3,1031.71.6833
dizziness1,7431.51.4272
diarrhoea2,0171.31.3159
off label use2,7261.31.3212
drug ineffective3,7151.21.2119
death1,7130.80.856

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.